The American Cancer Society (ACS), The University Of Illinois Cancer Center, the Big Ten Cancer Conference along with many others, are proud to be partnering Monday, October 2 on the 3^rd Annual #BeAGift Diversity in Clinical Trials Town Hall and Symposium and we would cordially invite you to attend this important conversation.  Historically, minority populations have been underrepresented in clinical trials, and as a result comprehensive responses to medicine based on sex, gender, race and lifestyle remain not well understood.   We hope you’ll consider joining us as we hear from diverse perspectives to call attention to this issue of importance in the public health community.  We will be dividing our event into three sections, to receive perspectives from:

• Medical professionals & health care leaders (current participants include Dr. Robert Winn, Director the UIC Cancer Center, Dr. Karriem Watson of the UIC Cancer Center, Dr. Susan Goodin from the Big Ten Cancer Research Consortium, along with a representative from Pfizer, Inc.);
• Patients and caregivers (current participants include Alicia Cook from the Chicago School of Professional Psychology, TaLana Huges of the Sickle Cell Disease Association of IL, and Star*Cunningham of 4D Healthware);
• Decision makers in the legislative space (current participants include IL State Representative Mary Flowers, among others)

This year’s event will be in a town hall format to foster discussion on increasing participation of diverse patient populations, along with fully exploring the policy landscape related to it.  Please join us for this event on Monday, October 2, 2017 from 9:30am-2:00pm at:

Access Center for Discovery and Learning

5139  S Ashland Ave

Chicago, IL 60609

To RSVP, please visit and register free of charge.  Lunch will be provided:

https://www.eventbrite.com/e/beagift-diversity-in-clinical-trials-tickets-38006818417